tradingkey.logo
tradingkey.logo
検索

Bio-Techne Corp

TECH
ウォッチリストに追加
71.000USD
0.0000.00%
終値 06/26, 16:00ET15分遅れの株価
11.07B時価総額
100.60直近12ヶ月PER

詳細情報 Bio-Techne Corp 企業名

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corpの企業情報

企業コードTECH
会社名Bio-Techne Corp
上場日Feb 09, 1989
最高経営責任者「CEO」Kelderman (Kim)
従業員数3100
証券種類Ordinary Share
決算期末Feb 09
本社所在地614 Mckinley Pl N E
都市MINNEAPOLIS
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号55413
電話番号16123798854
ウェブサイトhttps://www.bio-techne.com/
企業コードTECH
上場日Feb 09, 1989
最高経営責任者「CEO」Kelderman (Kim)

Bio-Techne Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.80K
+4.17%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
7.25K
+18.55%
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+43.36%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Mr. David Clair
Mr. David Clair
Investor Relations
Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.80K
+4.17%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%

よくある質問

Bio-Techne Corpの上位5名の株主は誰ですか?

Bio-Techne Corpの上位5名の株主は以下のとおりです。Mr. John L. Higgins

Bio-Techne Corp(TECH)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Bio-Techne Corpの株式を保有している機関は1247社あり、保有株式の総市場価値は約178.19Mで、全体の113.81%を占めています。2025Q4と比較して、機関の持ち株は1433.00増加しています。

Bio-Techne Corpの最大の収益源は何ですか?

2026Q1において、Consumables部門がBio-Techne Corpにとって最大の収益を生み出しており、その金額は235.44Mで、全収益の79.57%を占めています。
KeyAI